DOWN-MODULATION OF C-MYC EXPRESSION BY INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA PRECEDES GROWTH ARREST IN HUMAN-MELANOMA CELLS

被引:25
作者
OSANTO, S
JANSEN, R
VLOEMANS, M
机构
关键词
D O I
10.1016/0959-8049(92)90055-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
After in vitro incubation of melanoma tumour cells Cmel453A with either recombinant interferon gamma (rIFN-gamma) or tumour necrosis factor alpha (rTNF-alpha) a dose-dependent inhibition of cell growth occurred; when both cytokines were added, a synergistic action was observed. Inhibition of DNA synthesis, as measured by [H-3] thymidine incorporation, occurred after 6 h of incubation with rIFN-gamma or rTNF-alpha, and this action was potentiated when the two cytokines were applied simultaneously. Within 1 h, the level of c-myc mRNA in tumour cells had already decreased by, respectively, 60% (S.D. 7) and 25% (S.D. 7); the combined addition of the cytokines resulted in a greater reduction of c-myc mRNA than by each cytokine alone. Downregulation of c-myc expression is an early event, occurring hours before the actual inhibition of outgrowth. Thus, in melanoma cells like Cmel with a high constitutive expression of the c-myc oncogene, the antiproliferative action of rIFN-gamma and rTNF-alpha may be mediated by an inhibition of the expression of c-myc.
引用
收藏
页码:1622 / 1627
页数:6
相关论文
共 30 条
[1]   THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]  
AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303
[3]   N-MYC AMPLIFICATION CAUSES DOWN-MODULATION OF MHC CLASS-I ANTIGEN EXPRESSION IN NEUROBLASTOMA [J].
BERNARDS, R ;
DESSAIN, SK ;
WEINBERG, RA .
CELL, 1986, 47 (05) :667-674
[4]   IDENTIFICATION AND NUCLEOTIDE-SEQUENCE OF A HUMAN LOCUS HOMOLOGOUS TO THE V-MYC ONCOGENE OF AVIAN MYELOCYTOMATOSIS VIRUS MC29 [J].
COLBY, WW ;
CHEN, EY ;
SMITH, DH ;
LEVINSON, AD .
NATURE, 1983, 301 (5902) :722-725
[5]   RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR INCREASES MESSENGER-RNA LEVELS AND SURFACE EXPRESSION OF HLA-A,B ANTIGENS IN VASCULAR ENDOTHELIAL-CELLS AND DERMAL FIBROBLASTS INVITRO [J].
COLLINS, T ;
LAPIERRE, LA ;
FIERS, W ;
STROMINGER, JL ;
POBER, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (02) :446-450
[6]   INCREASED RATE OF DEGRADATION OF C-MYC MESSENGER-RNA IN INTERFERON-TREATED DAUDI CELLS [J].
DANI, C ;
MECHTI, N ;
PIECHACZYK, M ;
LEBLEU, B ;
JEANTEUR, P ;
BLANCHARD, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (15) :4896-4899
[7]  
EINAT M, 1988, ONCOGENE, V2, P485
[8]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[9]  
GUERIN M, 1988, ONCOGENE RES, V3, P21
[10]   A C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDE INHIBITS ENTRY INTO S-PHASE BUT NOT PROGRESS FROM G0 TO G1 [J].
HEIKKILA, R ;
SCHWAB, G ;
WICKSTROM, E ;
LOKE, SL ;
PLUZNIK, DH ;
WATT, R ;
NECKERS, LM .
NATURE, 1987, 328 (6129) :445-449